Provigate, Inc.
PrivateLast Round
Grant
Oct 28, 2024
Total Funding Raised
$13.33M
Company Overview
Provigate, Inc. is a healthcare technology company that develops non-invasive blood glucose monitoring sensors, devices, and digital health applications to support diabetes prevention and management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Provigate, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Provigate, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 28, 2024 | ||||
| Series B | Oct 28, 2024 | ||||
| VC Round | Jan 18, 2022 | ||||
| Strategic | Jan 18, 2022 | ||||
| VC Round | Sep 27, 2021 | ||||
Grant | Jul 29, 2021 |
Provigate, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tokyo Metropolitan Small and Medium Enterprise Support Center | Grant |
| Daikin Industries | VC Round |
| New Energy and Industrial Technology Development Organization | Grant |
| ANRI株式会社 | VC Round |
| Coral Capital | VC Round |
| Japan Science and Technology Agency | Series B, VC Round |
| SPARX Group | Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 28, 2024
$8M grant from New Energy and Industrial Technology Development Organization.
Provigate, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Provigate, Inc.'s valuation, stock price, and market status.